Literature DB >> 11602077

Algorithms for better arrhythmia discrimination in implantable cardioverter defibrillators.

R Schimpf1, C Wolpert, B Lüderitz.   

Abstract

The discrimination of concomitant atrial tachyarrhythmias and sinus tachycardias in patients with malignant ventricular tachyarrhythmias is a major challenge for new defibrillator devices. Different algorithms have now been established to distinguish between atrial and ventricular tachyarrhythmias. Furthermore, new dual-chamber implantable defibrillators are capable of tiered atrial therapies for both regular and irregular atrial and ventricular tachyarrhythmias. The increasingly complex and subtle dual-chamber detection algorithms have proven to be safe and effective for the detection of ventricular tachycardia, and also in terms of an increase in specificity and a reduction in inappropriate ventricular therapies for supraventricular tachyarrhythmias. Stable electrode position, and a continuous and correct atrial signal quality, are prerequisites for atrial therapies and algorithms for arrhythmia discrimination.

Entities:  

Mesh:

Year:  2001        PMID: 11602077     DOI: 10.1007/s11886-001-0068-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  21 in total

1.  [A new ICD morphology criterion for differentiating supraventricular and ventricular tachycardia].

Authors:  T Korte; H J Trappe; G Grönefeld; B Schulte; C Wolpert; M Meesmann; D Böcker; D Grosse Meininghaus; J Vogt; C Stellbrink
Journal:  Z Kardiol       Date:  2000-11

2.  Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and significance.

Authors:  D Bänsch; M Castrucci; D Böcker; G Breithardt; M Block
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

3.  First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.

Authors:  C Sticherling; A Schaumann; T Klingenheben; S H Hohnloser
Journal:  Europace       Date:  1999-04       Impact factor: 5.214

4.  Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators.

Authors:  M Weber; D Böcker; D Bänsch; J Brunn; M Castrucci; R Gradaus; G Breithardt; M Block
Journal:  J Cardiovasc Electrophysiol       Date:  1999-02

5.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Authors:  M Mirowski; P R Reid; M M Mower; L Watkins; V L Gott; J F Schauble; A Langer; M S Heilman; S A Kolenik; R E Fischell; M L Weisfeldt
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

6.  Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator.

Authors:  B Dijkman; H J Wellens
Journal:  J Cardiovasc Electrophysiol       Date:  2000-12

7.  Inappropriate detection of supraventricular arrhythmias by implantable dual chamber defibrillators: a comparison of four different algorithms.

Authors:  F Hintringer; S Schwarzacher; G Eibl; O Pachinger
Journal:  Pacing Clin Electrophysiol       Date:  2001-05       Impact factor: 1.976

Review 8.  Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: state-of-the-art review.

Authors:  C D Swerdlow
Journal:  J Cardiovasc Electrophysiol       Date:  2001-05

9.  Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator.

Authors:  C Wolpert; W Jung; C Scholl; S Spehl; J Cyran; B Lüderitz
Journal:  J Cardiovasc Electrophysiol       Date:  1998-08

10.  Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator.

Authors:  C D Swerdlow; T Ahern; P S Chen; C Hwang; E Gang; W Mandel; R M Kass; C T Peter
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.